For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of 4D Molecular Therapeutics Inc (NASDAQ: FDMT) was $7.59 for the day, down -3.19% from the previous closing price of $7.84. In other words, the price has decreased by -$3.19 from its previous closing price. On the day, 0.55 million shares were traded. FDMT stock price reached its highest trading level at $7.935 during the session, while it also had its lowest trading level at $7.5.
Ratios:
Our analysis of FDMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.33 and its Current Ratio is at 17.33. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on November 21, 2024, initiated with a Underweight rating and assigned the stock a target price of $8.
On April 15, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $459.Barclays initiated its Overweight rating on April 15, 2024, with a $459 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 16 ’24 when Bizily Scott sold 500 shares for $16.33 per share. The transaction valued at 8,165 led to the insider holds 6,781 shares of the business.
Bizily Scott sold 500 shares of FDMT for $7,500 on Aug 19 ’24. The Chief Legal Officer now owns 6,781 shares after completing the transaction at $15.00 per share. On Jul 16 ’24, another insider, Bizily Scott, who serves as the Chief Legal Officer of the company, sold 1,750 shares for $27.11 each. As a result, the insider received 47,442 and left with 6,781 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FDMT now has a Market Capitalization of 350868256. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.90 while its Price-to-Book (P/B) ratio in mrq is 0.71.
Stock Price History:
Over the past 52 weeks, FDMT has reached a high of $36.25, while it has fallen to a 52-week low of $7.32. The 50-Day Moving Average of the stock is -14.01%, while the 200-Day Moving Average is calculated to be -60.93%.
Shares Statistics:
FDMT traded an average of 897.63K shares per day over the past three months and 1049770 shares per day over the past ten days. A total of 52.00M shares are outstanding, with a floating share count of 39.01M. Insiders hold about 15.61% of the company’s shares, while institutions hold 112.67% stake in the company. Shares short for FDMT as of 1731628800 were 7827058 with a Short Ratio of 8.72, compared to 1728950400 on 9490542. Therefore, it implies a Short% of Shares Outstanding of 7827058 and a Short% of Float of 17.62.
